These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16175687)

  • 1. Allocation concealment and blinding: when ignorance is bliss.
    Hemilä H
    Med J Aust; 2005 Aug; 183(3):165-6; author reply 166. PubMed ID: 16175687
    [No Abstract]   [Full Text] [Related]  

  • 2. Allocation concealment and blinding: when ignorance is bliss.
    Berger VW
    Med J Aust; 2005 Aug; 183(3):165; author reply 166. PubMed ID: 16053426
    [No Abstract]   [Full Text] [Related]  

  • 3. Allocation concealment and blinding: when ignorance is bliss.
    Forder PM; Gebski VJ; Keech AC
    Med J Aust; 2005 Jan; 182(2):87-9. PubMed ID: 15651970
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing allocation concealment and blinding in randomised controlled trials: why bother?
    Schulz KF
    Evid Based Nurs; 2001 Jan; 4(1):4-6. PubMed ID: 11707879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 6. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
    Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
    J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
    Pildal J; Hróbjartsson A; Jørgensen KJ; Hilden J; Altman DG; Gøtzsche PC
    Int J Epidemiol; 2007 Aug; 36(4):847-57. PubMed ID: 17517809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trials: allocation concealment, random allocation, and blinding.
    Sedgwick P
    BMJ; 2015 May; 350():h2633. PubMed ID: 25979365
    [No Abstract]   [Full Text] [Related]  

  • 12. Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2011 Oct; 64(10):1070-5. PubMed ID: 21474279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing allocation concealment and blinding in randomised controlled trials: why bother?
    Schulz KF
    Equine Vet J; 2005 Sep; 37(5):394-5. PubMed ID: 16163939
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blinding of an acupuncture randomized controlled trial optimized with clinical translational science award resources.
    Steffen AD; Burke LA; Pauls HA; Suarez ML; Yao Y; Kobak WH; Takayama M; Yajima H; Kaptchuk TJ; Takakura N; Wilkie DJ; Schlaeger JM
    Clin Trials; 2020 Oct; 17(5):545-551. PubMed ID: 32650673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 18. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
    Polit DF; Gillespie BM; Griffin R
    Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.